Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells

scientific article published on April 2006

Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1039669931
P356DOI10.1080/13550280600716604
P8608Fatcat IDrelease_rruplx7n7vbnnf4odnanniiasi
P698PubMed publication ID16798673

P50authorE. Tessa Hedley-WhyteQ120721373
P2093author name stringSantosh Kesari
Kenneth Williams
Christian Wüthrich
Igor J Koralnik
Rebecca Gelman
Woong-Ki Kim
Umberto De Girolami
Jeffrey T Joseph
Derek Elmeric
P2860cites workProgressive multifocal leukoencephalopathy in a patient treated with natalizumabQ28255536
Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosisQ28255548
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's diseaseQ28255557
Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).Q30787775
JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.Q33838943
Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathyQ34201921
A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.Q34328813
Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathyQ34399011
Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's diseaseQ34538727
Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.Q36890313
AIDS-associated progressive multifocal leukoencephalopathy (PML): comparison to non-AIDS PML with in situ hybridization and immunohistochemistryQ43409628
The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious diseaseQ43639344
Identification of T lymphocytes in simian immunodeficiency virus encephalitis: distribution of CD8+ T cells in association with central nervous system vessels and virusQ43899457
Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.Q44431490
Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathyQ45057240
Atypical progressive multifocal leukoencephalopathy with plasma-cell infiltratesQ48480551
Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequencesQ48860550
Patients at RiskQ53473917
Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathyQ77336908
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficitsQ80020017
P433issue2
P921main subjectprogressive multifocal leukoencephalopathyQ704930
lymphocyteQ715347
P304page(s)116-128
P577publication date2006-04-01
P1433published inJournal of NeuroVirologyQ6295640
P1476titleCharacterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells
P478volume12

Reverse relations

cites work (P2860)
Q81408225Central nervous system graft-versus-host disease: consider progressive multifocal leukoencephalopathy among the differential diagnoses
Q44740656Collateral neuronal apoptosis in CNS gray matter during an oligodendrocyte-directed CD8(+) T cell attack.
Q33547027Demyelinating disorders
Q33945721Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation
Q37697448Differences in T cell cytotoxicity and cell death mechanisms between progressive multifocal leukoencephalopathy, herpes simplex virus encephalitis and cytomegalovirus encephalitis.
Q43115882Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy
Q35785136Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy
Q37088626Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy
Q33834119Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons
Q21285083Human polyomavirus reactivation: disease pathogenesis and treatment approaches
Q40764534Immune suppression of JC virus gene expression is mediated by SRSF1.
Q37678580Immune surveillance and response to JC virus infection and PML.
Q38367755Immunology of progressive multifocal leukoencephalopathy.
Q37198798Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis
Q34545686Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy
Q38379787JC Virus Infects Neurons and Glial Cells in the Hippocampus
Q34120183JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy
Q35864067Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System
Q41361912MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Q40792696Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant
Q24619923Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain
Q35736438Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study
Q26822247New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy
Q30613846PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section
Q37828002Pathogenesis of progressive multifocal leukoencephalopathy--revisited
Q30235523Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.
Q38577593Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
Q33893285Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
Q34529503Pur-Alpha Induces JCV Gene Expression and Viral Replication by Suppressing SRSF1 in Glial Cells
Q37951338Role of p53 in neurodegenerative diseases
Q26859307The importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathy
Q41953075The roles of CD8 central and effector memory T-cell subsets in allograft rejection.

Search more.